Pharmacological antiemetic prophylaxis and treatment for opioid-induced nausea and vomiting (OINV) in patients treated for cancer pain and cancer-related breathlessness.

IF 8.8 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

Cochrane Database of Systematic Reviews Pub Date : 2025-08-29 DOI:10.1002/14651858.CD016207

Jan Gaertner, Christian Appenzeller-Herzog, Vanessa Piechotta, Guido Schwarzer, Constanze Rémi, Katja Suter, Christopher Boehlke

引用次数: 0

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of pharmacological treatments given prophylactically or on-demand after onset of opioid-induced nausea and vomiting (OINV) in people being treated for cancer pain or cancer dyspnoea, when compared to placebo or other pharmacological interventions.

查看原文本刊更多论文

药物止吐预防和治疗阿片类药物引起的癌症疼痛和癌症相关呼吸困难患者的恶心和呕吐（OINV）

目的：这是Cochrane综述（干预）的一个方案。目的如下：与安慰剂或其他药物干预相比，评估在接受癌症疼痛或癌症呼吸困难治疗的患者发生阿片类药物诱导的恶心和呕吐（OINV）后预防性或按需给予药物治疗的益处和危害。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cochrane Database of Systematic Reviews 医学-医学：内科

CiteScore

10.60

自引率

2.40%

发文量

173

审稿时长

1-2 weeks

期刊介绍： The Cochrane Database of Systematic Reviews (CDSR) stands as the premier database for systematic reviews in healthcare. It comprises Cochrane Reviews, along with protocols for these reviews, editorials, and supplements. Owned and operated by Cochrane, a worldwide independent network of healthcare stakeholders, the CDSR (ISSN 1469-493X) encompasses a broad spectrum of health-related topics, including health services.